Showing results (551-560 of 776) with videos related to
Sort By:
Pageof 78
JAMA Dermatology|March 26, 2015
Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host DiseaseEric Sorenson, Rachel McAndrew, Viraat Patel, et al.Journal of the American Academy of Dermatology|April 14, 2018
Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque psoriasisClaus Zachariae, Kenneth Gordon, Alexandra B Kimball, et al.Journal of Drugs in Dermatology : JDD|May 6, 2025
Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus PanelJoshua Burshtein, Milaan Shah, Danny Zakria, et al.Journal of the American Academy of Dermatology|April 17, 2018
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)Mark Lebwohl, Andrew Blauvelt, Carle Paul, et al.Free Radical Biology & Medicine|October 11, 2005
Benzo[a]pyrene and its metabolites combined with ultraviolet A synergistically induce 8-hydroxy-2'-deoxyguanosine via reactive oxygen speciesDayuan Gao, Yunjing Luo, Denise Guevara, et al.Journal of the American Academy of Dermatology|October 4, 2005
Oral phosphate binders in the treatment of pseudoxanthoma elasticumDaniel W Sherer, Giselle Singer, Jaime Uribarri, et al.Archives of Dermatological Research|April 29, 2025
Systemic Janus kinase inhibitors in the management of granuloma annulareScott Stratman, Shivkar Amara, Kathryn Jayne Tan, et al.Plos One|June 16, 2011
Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritisKnut M Wittkowski, Craig Leonardi, Alice Gottlieb, et al.Journal of the American Academy of Dermatology|October 16, 2007
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialAlan Menter, Stephen K Tyring, Kenneth Gordon, et al.Cutis|October 2, 2002
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeksJonathan Weiss, Alan Menter, Oscar Hevia, et al.Pageof 78